Klein Matthew B. 4
4 · ClearPoint Neuro, Inc. · Filed May 19, 2025
Insider Transaction Report
Form 4
Klein Matthew B.
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-05-16−21,093→ 0 total→ Common Stock (21,093 underlying) - Exercise/Conversion
Common Stock
2025-05-16+21,093→ 50,518 total
Footnotes (1)
- [F1]Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.